ஹெடரொ ஆய்வகங்கள் வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஹெடரொ ஆய்வகங்கள் வரையறுக்கப்பட்டவை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஹெடரொ ஆய்வகங்கள் வரையறுக்கப்பட்டவை Today - Breaking & Trending Today

Fake Remdesivir racket busted in Haryana, 11 arrested

URL copied
Fake Remdesivir racket busted in Haryana, 11 arrested
The Food and Drugs Administration department of Haryana has busted a racket involved in manufacturing large quantities of fake Remdesivir injections. A total of 11 people have been arrested so far in the case by the Crime Investigation Agency (CIA) of the police.
According to police, the accused were allegedly selling Meroprnem, as Remdesivir vials by printing fake stickers of M/s Hetero Labs Limited, a company producing the drug.
Police said that 277 vials with fake stickers were recovered. More than 3,300 boxes of Meroprnem were also recovered.
Remdesivir is an antiviral drug used in the treatment of Covid patients. ....

Himachal Pradesh , Crime Investigation Agency , Drugs Administration Department , Hetero Labs , Image Source , Fake Remdesivir , Drugs Administration , Hetero Labs Limited , இமாச்சல் பிரதேஷ் , ஹெடரொ ஆய்வகங்கள் , படம் மூல , ஹெடரொ ஆய்வகங்கள் வரையறுக்கப்பட்டவை ,

American Pharma Company Making Oral Drug To Treat Non-Hospitalised Covid-19 Patients Enters Into Agreement With Five Indian Manufacturers

by Swarajya Staff - May 3, 2021 08:17 AM
Merck Pharma
Snapshot
Molnupiravir is currently undergoing a phase-3 trial for the treatment of non-hospitalised patients with confirmed Covid-19.
An experimental oral antiviral drug called molnupiravir, manufactured by the American pharmaceutical company, Merck, is expected to help stem the cases of coronavirus in India.
The company, which is also known as MSD outside the United States and Canada, announced earlier last week that it has entered into non-exclusive voluntary licensing agreements for the drug with five established Indian generics manufacturers.
Even though there are two Covid-19 vaccines in IndiaâCovaxin and Covishieldâ it is believed that molnupiravir would play a key role in fighting the massive health crisis in the country. ....

United States , Umang Vohra , Ridgeback Biotherapeutics , Kennethc Frazier , Cipla Ltd , Dr Reddy Laboratories , Sun Pharmaceutical Industries , Emory University , Emcure Pharmaceuticals , Hetero Labs , Laboratories Limited , Emcure Pharmaceuticals Limited , Hetero Labs Limited , Medicines Patent Pool , Geneva Based Unitaid Backed , Eastern Equine Encephalitis , Drug Innovation Ventures , ஒன்றுபட்டது மாநிலங்களில் , உமங் வோஹ்ரா , சிப்லா லிமிடெட் , டாக்டர் சிவப்பு ஆய்வகங்கள் , சூரியன் மருந்து தொழில்கள் , உணர்ச்சி பல்கலைக்கழகம் , ஹெடரொ ஆய்வகங்கள் , ஆய்வகங்கள் வரையறுக்கப்பட்டவை , ஹெடரொ ஆய்வகங்கள் வரையறுக்கப்பட்டவை ,

Buenos Aires Times | Sputnik VIDA vaccine will be 'principally for Argentina'

Sputnik VIDA. | Art by Joaquín Temes
The Sputnik VIDA vaccine, manufactured by local pharmaceutical firm Laboratorios Richmond, will be used in principle for the Argentine State, company chief Marcelo Figueiras has confirmed.
Speaking after his company and the Russian Direct Investment Fund (RDIF) announced this week that Argentina had become the first country in Latin America to begin production of the Sputnik V coronavirus vaccine, Figueiras expressed his delight at the “good news” and praised the skill of the nation’s scientists.
The 57-year-old then confirmed that the initial doses produced by the firm will be used “in principle, for the Argentina State, while the pandemic lasts.” ....

United States , South Korea , Marcelo Figueiras , Alberto Fern , Kirill Dmitriev , Laboratorios Richmond , Productive Development Ministry , Gamaleya Research Institute , Productive Development , Hetero Labs , Russian Direct Investment Fund , Argentine State , Latin America , Argentina State , Radio Con Vos , Gamaleya Research , South America , Development Minister Mat , President Alberto Fern , Hetero Labs Limited , Marcelo Figueras , Sputnik V , Covid 19 , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா , மார்செலோ பிகுேரச் ,

Antiviral drug invented by Emory's DRIVE licensed in India for COVID-19 emergency | Emory University

Tags »
To address the intensifying COVID-19 crisis in India, the pharmaceutical company Merck has agreed to facilitate the manufacture and distribution of molnupiravir, an investigational antiviral drug that was discovered at Emory.
“To advance a drug quickly and across the globe in all the countries where it is needed, you need the capacity of a company like Merck,” said George Painter, PhD, CEO of the non-profit Emory-owned DRIVE (Drug Innovation Ventures at Emory), at a media briefing Tuesday. “It’s gratifying to see how quickly they moved and how they’re getting this into the hands of people in India to meet this threat.” ....

United States , Ridgeback Biotherapeutics , Kennethc Frazier , Sun Pharmaceutical Industries , World Health Organization , Emcure Pharmaceuticals , Hetero Labs , Reddy Laboratories , George Painter , Drug Innovation Ventures , Cipla Limited , Laboratories Limited , Emcure Pharmaceuticals Limited , Hetero Labs Limited , Sun Pharmaceutical Industries Limited , ஒன்றுபட்டது மாநிலங்களில் , சூரியன் மருந்து தொழில்கள் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , ஹெடரொ ஆய்வகங்கள் , சிவப்பு ஆய்வகங்கள் , ஜார்ஜ் ஓவியர் , மருந்து கண்டுபிடிப்பு முயற்சிகள் , சிப்லா வரையறுக்கப்பட்டவை , ஆய்வகங்கள் வரையறுக்கப்பட்டவை , ஹெடரொ ஆய்வகங்கள் வரையறுக்கப்பட்டவை , சூரியன் மருந்து தொழில்கள் வரையறுக்கப்பட்டவை ,

Buenos Aires Times | Sputnik VIDA vaccine will be 'principally for Argentina'

Sputnik VIDA. | Art by Joaquín Temes
The Sputnik VIDA vaccine, manufactured by local pharmaceutical firm Laboratorios Richmond, will be used in principle for the Argentine State, company chief Marcelo Figueiras has confirmed.
Speaking after his company and the Russian Direct Investment Fund (RDIF) announced this week that Argentina had become the first country in Latin America to begin production of the Sputnik V coronavirus vaccine, Figueiras expressed his delight at the “good news” and praised the skill of the nation’s scientists.
The 57-year-old then confirmed that the initial doses produced by the firm will be used “in principle, for the Argentina State, while the pandemic lasts.” ....

United States , South Korea , Marcelo Figueiras , Alberto Fern , Kirill Dmitriev , Laboratorios Richmond , Productive Development Ministry , Gamaleya Research Institute , Productive Development , Hetero Labs , Russian Direct Investment Fund , Argentine State , Latin America , Argentina State , Radio Con Vos , Gamaleya Research , South America , Development Minister Mat , President Alberto Fern , Hetero Labs Limited , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா , மார்செலோ பிகுேரச் , ஆல்பர்டோ ஃபெர்ன் , ப்ரொடக்டிவ் வளர்ச்சி அமைச்சகம் , ப்ரொடக்டிவ் வளர்ச்சி ,